Analysis of Medicare Prescription Drug Plans in 2011 and Key Trends Since 2006
This report presents findings from an analysis of the Medicare Part D marketplace in 2011 and changes in drug coverage and costs since 2006.
View the Latest: Prescription Drugs
Filter
-
-
-
-
-
Weighted Average Monthly Premium for Medicare Part D Stand-alone Prescription Drug Plans
State Health Facts Indicator -
A Profile of African Americans, Latinos, and Whites with Medicare:
ReportThis chartpack highlights demographic data about African Americans, Hispanics and whites with Medicare to highlight potential implications for outreach efforts under the new Medicare drug benefit. The information is being used in a series of November 2005 briefings at the start of the first open-enrollment period for the new benefit. Chartpack (.
-
Snapshots: Effect of Tying Eligibility for Health Insurance Subsidies to the Federal Poverty Level
Issue BriefConsiderable attention has been paid in recent years to the rapid growth of health insurance premiums and its impact on coverage affordability. Premium growth has far outpaced growth in workers earnings, which means that workers have to spend more of their income each year on health care to maintain current coverage levels.
-
Snapshots: Insurance Premium Cost-Sharing and Coverage Take-up
Issue BriefOne of the many reasons an individual may be uninsured is that she or he decides an employer’s offer of health insurance is too expensive. Several studies have noted the likelihood that a worker will decline an employer’s offer of health insurance increases with the amount he or she is required to contribute.
-
Snapshots: Comparing Projected Growth in Health Care Expenditures and the Economy
Issue BriefThe rising cost of health care is much in the news.
-
Transitions 2006
VideoOn January 1, 2006, the six million Americans who are covered by both Medicare and Medicaid saw a change in how their prescription drugs are covered. The dual eligible population was transitioned from Medicaid into the Medicare prescription drug benefit. As a group, these beneficiaries are poorer and sicker than those on Medicare. Consequently, they have more extensive health and prescription drug needs than most Medicare beneficiaries.